FDA recall record

Cargill Sea Salt Tablets recall — FDA F-0018-2018

Equipment malfunction resulted in the inclusion of very small metallic fragments and particulate matter in some lots of salt tablets.

Class IIIclassification
F-0018-2018official record ID
Oct 18, 2017report date

Recall record at a glance

Official recordF-0018-2018
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmCargill Salt
Report dateOct 18, 2017
Recall initiation dateSep 18, 2017
Quantity800 cases
LocationNewark, CA, United States

Official product description

Cargill Sea Salt Tablets; Net Wt. 50 lbs. (22.7 kg) cardboard case. 40 grain salt tablets; Ingredients: Salt Cargill Incorporated Minneapolis, MN 55440

Why the product was recalled

Equipment malfunction resulted in the inclusion of very small metallic fragments and particulate matter in some lots of salt tablets.

Distribution information

one distributor and two customers, all in WA state

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.